SOCMA report finds companies ‘bullish’
Submitted by:
Andrew Warmington
A new report by SOCMA and Vault Consulting, the Specialty Chemicals Industry Census, has found
Evotec initiates ‘Campus Curie’ in Toulouse
Submitted by:
Andrew Warmington
Drug discovery firm Evotec, which also owns the CDMO Aptuit, has acquired the ‘Biopark by Sanofi’
Covid-19: Four more events postponed
Submitted by:
Andrew Warmington
At the end of June, three more major exhibitions that attract high attendances from the
Carlyle Group invests in Piramal
Submitted by:
Andrew Warmington
Via CA Clover Intermediate II Investments, private equity firm the Carlyle Group is to invest
Nouryon completes two moves
Submitted by:
Andrew Warmington
Nouryon has completed two recently announced advances: the acquisition of the carboxymethyl cellulose (CMC) business
Clariant continues speciality drive
Submitted by:
Andrew Warmington
Clariant has taken what exective chairman Hariold Kottmann (above) called “another significant step
Bayer resolves most Monsanto litigation
Submitted by:
Andrew Warmington
Bayer has made a series of agreements that, it said, “will substantially resolve” major outstanding
Solvay to take impairment
Submitted by:
Andrew Warmington
In a Q2 trading update, Solvay revealed that an impairment review is under way and
Syngenta Group launched
Submitted by:
Andrew Warmington
Syngenta Group, which describes itself as “a new global leader in agricultural science and innovation”
Syngenta Group launched
Submitted by:
Andrew Warmington
Syngenta Group, which describes itself as “a new global leader in agricultural science and innovation”